Roux-en-Y gastric bypass alleviates hypertension and is associated with an increase in mid-regional pro-atrial natriuretic peptide in morbid obese patients

Journal of Hypertension

Volumn 33, Issue 6, 2015, Pages 1215-1225

  Bonfils, Peter K ^a   Taskiran, Mustafa ^a   Damgaard, Morten ^a   Goetze, Jens P ^b   Floyd, Andrea K ^a   Funch Jensen, Peter ^c,d   Kristiansen, Viggo B ^a   Støckel, Mikael ^c   Bouchelouche, Pierre N ^a   Gadsbøll, Niels ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Rigshospitalet   (Denmark)

^c Aleris Hamlet ^*  (Denmark)

^d AARHUS UNIVERSITY   (Denmark)

Author keywords

bariatric surgery; gastric bypass; glomerular filtration rate; hypertension; natriuretic peptides; obesity; salt sensitivity; sodium; weight loss

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATRIAL NATRIURETIC FACTOR; MIDREGIONAL PRO-ATRIAL NATRIURETIC PEPTIDE, HUMAN;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD ANALYSIS; BLOOD PRESSURE MONITORING; BODY FLUID COMPARTMENT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEART OUTPUT; HEART STROKE VOLUME; HEMODYNAMICS; HIGH SODIUM INTAKE; HUMAN; HYPERTENSION; LAPAROSCOPIC ROUX EN Y GASTRIC BYPASS; LAPAROSCOPIC SURGERY; LOW SODIUM INTAKE; MALE; MORBID OBESITY; PLASMA VOLUME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; ROUX Y ANASTOMOSIS; SODIUM INTAKE; STOMACH BYPASS; WEIGHT REDUCTION; BLOOD; BLOOD PRESSURE; GASTRIC BYPASS SURGERY; LAPAROSCOPY; METABOLISM; MIDDLE AGED; OBESITY, MORBID; RANDOMIZED CONTROLLED TRIAL; TIME FACTOR;

ADULT; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE; FEMALE; GASTRIC BYPASS; HUMANS; HYPERTENSION; LAPAROSCOPY; MALE; MIDDLE AGED; OBESITY, MORBID; TIME FACTORS; WEIGHT LOSS;

EID: 84929463006     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000526     Document Type: Article

References (48)

1. Straznicky N, Grassi G, Esler M, Lambert G, Dixon J, Lambert E, et al. European Society of Hypertension Working Group on Obesity Antihypertensive effects of weight loss: myth or reality? J Hypertens 2010; 28:637-643.
2. Jordan J, Yumuk V, Schlaich M, Nilsson PM, Zahorska-Markiewicz B, Grassi G, et al. Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and difficult to treat arterial hypertension. J Hypertens 2012; 30:1047-1055.
3. Sjostrom L, Peltonen M, Jacobson P, Sjostrom CD, Karason K, Wedel H, et al. Bariatric surgery and long-term cardiovascular events. JAMA 2012; 307:56-65.
4. Sjostrom L. Review of the key results from the Swedish Obese Subjects (SOS) trial: a prospective controlled intervention study of bariatric surgery. J Intern Med 2013; 273:219-234.
5. Hallersund P, Sjostrom L, Olbers T, Lonroth H, Jacobson P, Wallenius V, et al. Gastric bypass surgery is followed by lowered blood pressure and increased diuresis: long term results from the Swedish Obese Subjects (SOS) study. PLoS One 2012; 7:e49696.
6. Beleigoli AM, Diniz MF, Ribeiro AL. Natriuretic peptides: linking heart and adipose tissue in obesity and related conditions-a systematic review. Obes Rev 2009; 10:617-626.
7. Clerico A, Giannoni A, Vittorini S, Emdin M. The paradox of low BNP levels in obesity. Heart Fail Rev 2012; 17:81-96.
8. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Wilson PW, Vasan RS. Impact of obesity on plasma natriuretic peptide levels. Circulation 2004; 109:594-600.
9. Vesely DL. Atrial natriuretic peptide prohormone gene expression: hormones and diseases that upregulate its expression. IUBMB Life 2002; 53:153-159.
10. Bartels ED, Nielsen JM, Bisgaard LS, Goetze JP, Nielsen LB. Decreased expression of natriuretic peptides associated with lipid accumulation in cardiac ventricle of obese mice. Endocrinology 2010; 151:5218-5225.
11. Gabrielsen A, Videbaek R, Schou M, Damgaard M, Kastrup J, Norsk P. Noninvasive measurement of cardiac output in heart failure patients using a new foreign gas rebreathing technique. Clin Sci (Lond) 2002; 102:247-252.
12. Hunter I, Alehagen U, Dahlstrom U, Rehfeld JF, Crimmins DL, Goetze JP. N-terminal pro-atrial natriuretic peptide measurement in plasma suggests covalent modification. Clin Chem 2011; 57:1327-1330.
13. Bonfils PK, Damgaard M, Stokholm KH, Nielsen SL. 99mTc-albumin can replace 125I-albumin to determine plasma volume repeatedly. Scand J Clin Lab Invest 2012; 72:447-451.
14. Brochner-Mortensen J. A simple single injection method for determination of the extracellular fluid volume. Scand J Clin Lab Invest 1980; 40:567-573.
15. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K. Bariatric surgery: a systematic review and metaanalysis. JAMA 2004; 292:1724-1737.
16. Fernstrom JD, Courcoulas AP, Houck PR, Fernstrom MH. Long-term changes in blood pressure in extremely obese patients who have undergone bariatric surgery. Arch Surg 2006; 141:276-283.
17. Heneghan HM, Meron-Eldar S, Brethauer SA, Schauer PR, Young JB. Effect of bariatric surgery on cardiovascular risk profile. Am J Cardiol 2011; 108:1499-1507.
18. Hinojosa MW, Varela JE, Smith BR, Che F, Nguyen NT. Resolution of systemic hypertension after laparoscopic gastric bypass. J Gastrointest Surg 2009; 13:793-797.
19. Segal JB, Clark JM, Shore AD, Dominici F, Magnuson T, Richards TM, et al. Prompt reduction in use of medications for comorbid conditions after bariatric surgery. Obes Surg 2009; 19:1646-1656.
20. Sjostrom L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004; 351:2683-2693.
21. Ahmed AR, Rickards G, Coniglio D, Xia Y, Johnson J, Boss T, O'Malley W. Laparoscopic Roux-en-Y gastric bypass and its early effect on blood pressure. Obes Surg 2009; 19:845-849.
22. Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer X, Eckel RH. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss. Circulation 2006; 113:898-918.
23. Alpert MA, Omran J, Mehra A, Ardhanari S. Impact of obesity and weight loss on cardiac performance and morphology in adults. Prog Cardiovasc Dis 2014; 56:391-400.
24. Bonfils PK, Taskiran M, Damgaard M, Goetze JP, Floyd AK, Funch-Jensen P, et al. The influence of high versus low sodium intake on blood pressure and hemodynamics in patients with morbid obesity. J Hypertens 2013; 31:2220-2229.
25. Macheret F, Heublein D, Costello-Boerrigter LC, Boerrigter G, McKie P, Bellavia D, et al. Human hypertension is characterized by a lack of activation of the antihypertensive cardiac hormones ANP and BNP. J Am Coll Cardiol 2012; 60:1558-1565.
26. Changchien EM, Ahmed S, Betti F, Higa J, Kiely K, Hernandez-Boussard T, Morton J. B-type natriuretic peptide increases after gastric bypass surgery and correlates with weight loss. Surg Endosc 2011; 25:2338-2343.
27. Chen-Tournoux A, Khan AM, Baggish AL, Castro VM, Semigran MJ, McCabe EL, et al. Effect of weight loss after weight loss surgery on plasma N-terminal pro-B-type natriuretic peptide levels. Am J Cardiol 2010; 106:1450-1455.
28. St Peter JV, Hartley GG, Murakami MM, Apple FS. B-type natriuretic peptide (BNP) and N-terminal pro-BNP in obese patients without heart failure: relationship to body mass index and gastric bypass surgery. Clin Chem 2006; 52:680-685.
29. Zois NE, Bartels ED, Hunter I, Kousholt BS, Olsen LH, Goetze JP. Natriuretic peptides in cardiometabolic regulation and disease. Nat Rev Cardiol 2014; 11:403-412.
30. Khan AM, Cheng S, Magnusson M, Larson MG, Newton-Cheh C, McCabe EL, et al. Cardiac natriuretic peptides, obesity, and insulin resistance: evidence from two community-based studies. J Clin Endocrinol Metab 2011; 96:3242-3249.
31. Sicard RE, Feit L, Werner JC. Insulin reduces basal release of atrial natriuretic factor by isolated, perfused neonatal pig hearts. Biol Neonate 1993; 64:221-227.
32. Faria G, Preto J, da Costa EL, Guimaraes JT, Calhau C, Taveira-Gomes A. Acute improvement in insulin resistance after laparoscopic Roux-en-Y gastric bypass: is 3 days enough to correct insulin metabolism? Obes Surg 2013; 23:103-110.
33. Mingrone G, Panunzi S, De GA, Guidone C, Iaconelli A, Leccesi L, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 2012; 366:1577-1585.
34. le Roux CW, Aylwin SJ, Batterham RL, Borg CM, Coyle F, Prasad V, et al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg 2006; 243:108-114.
35. Kim M, Platt MJ, Shibasaki T, Quaggin SE, Backx PH, Seino S, et al. GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure. Nat Med 2013; 19:567-575.
36. Arone LJ, Mackintosh R, Rosenbaum M, Leibel RL, Hirsch J. Autonomic nervous system activity in weight gain and weight loss. Am J Physiol 1995; 269:R222-R225.
37. Hall JE. Mechanisms of abnormal renal sodium handling in obesity hypertension. Am J Hypertens 1997; 10:49S-55S.
38. Rocchini AP. Obesity hypertension, salt sensitivity and insulin resistance. Nutr Metab Cardiovasc Dis 2000; 10:287-294.
39. Thakur V, Richards R, Reisin E. Obesity, hypertension, and the heart. Am J Med Sci 2001; 321:242-248.
40. Brochner-Mortensen J, Rickers H, Balslev I. Renal function and body composition before and after intestinal bypass operation in obese patients. Scand J Clin Lab Invest 1980; 40:695-702.
41. Stokholm KH, Hoilund-Carlsen PF, Brochner-Mortensen J. Glomerular filtration rate after jejunoileal bypass for obesity. Int J Obes 1981; 5:77-80.
42. Fenske WK, Dubb S, Bueter M, Seyfried F, Patel K, Tam FW, et al. Effect of bariatric surgery-induced weight loss on renal and systemic inflammation and blood pressure: a 12-month prospective study. Surg Obes Relat Dis 2013; 9:559-568.
43. Navarro-Diaz M, Serra A, Romero R, Bonet J, Bayes B, Homs M, et al. Effect of drastic weight loss after bariatric surgery on renal parameters in extremely obese patients: long-term follow-up. J Am Soc Nephrol 2006; 17:S213-S217.
44. Serpa NA, Bianco Rossi FM, Dal Moro AR, Alves BN, Cunha Barbosa SG, Rossi M. Effect of weight loss after Roux-en-Y gastric bypass, on renal function and blood pressure in morbidly obese patients. J Nephrol 2009; 22:637-646.
45. Helal I, Fick-Brosnahan GM, Reed-Gitomer B, Schrier RW. Glomerular hyperfiltration: definitions, mechanisms and clinical implications. Nat Rev Nephrol 2012; 8:293-300.
46. Fang Z, Sripairojthikoon W, Calhoun DA, Zhu S, Berecek KH, Wyss JM. Interaction between lifetime captopril treatment and NaCI-sensitive hypertension in spontaneously hypertensive rats and Wistar-Kyoto rats. J Hypertens 1999; 17:983-991.
47. Wyss JM, Roysommuti S, King K, Kadisha I, Regan CP, Berecek KH. Salt-induced hypertension in normotensive spontaneously hypertensive rats. Hypertension 1994; 23:791-796.
48. Pimenta E, Gaddam KK, Oparil S, Aban I, Husain S, Dell'Italia LJ, Calhoun DA. Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial. Hypertension 2009; 54:475-481.